Related Experiment Video

Updated: Jun 8, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

What can the molecular pathologist offer for optimal decision making?

S D Richman1, G G A Hutchins, M T Seymour

  • 1Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, Leeds, UK.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|October 15, 2010
PubMed

Insights

Molecular biomarkers are crucial for managing advanced colorectal cancer. Identifying specific genetic mutations, like KRAS, helps predict treatment response and improve patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Advanced colorectal cancer treatment is complex due to innovative therapies.
  • Validated molecular biomarkers are essential for patient management but were not routinely used.
  • The KRAS oncogene's activating mutations predict resistance to anti-epidermal growth factor receptor agents, highlighting biomarker importance.

Purpose of the Study:

  • To discuss the clinical value of biomarkers in advanced colorectal cancer.
  • To explore prognostic and predictive biomarkers reflecting molecular and therapeutic complexities.
  • To emphasize how biomarkers can improve patient management and therapeutic agent selection.

Main Methods:

  • Review of current literature on molecular biomarkers in advanced colorectal cancer.
  • Analysis of the role of KRAS mutations in predicting treatment response.
  • Discussion of prognostic and predictive biomarker utility.

Main Results:

  • Biomarkers, particularly KRAS mutations, are vital for predicting resistance to anti-EGFR therapies.
  • Prognostic and predictive biomarkers offer insights into clinical outcomes.
  • Biomarker-guided selection improves therapeutic agent choice.

Conclusions:

  • Molecular biomarkers are increasingly important in advanced colorectal cancer management.
  • Understanding genetic mutations like KRAS enhances personalized treatment strategies.
  • Biomarkers facilitate better patient outcomes and optimized therapy selection.

More Related Videos

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Related Concept Videos

Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
Applications of Molecular Taxonomy01:20

Applications of Molecular Taxonomy

Molecular taxonomy has revolutionized the understanding and classification of bacteria, providing precise insights into their diversity, evolutionary relationships, and ecological roles. By utilizing molecular techniques such as DNA sequencing and fingerprinting, researchers have made significant strides in various fields related to bacterial studies.Resolving Taxonomic AmbiguitiesMolecular taxonomy has been instrumental in distinguishing closely related bacterial species initially thought to...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...